Molecular Design of Bifunctional Cp*Ru Catalysts for Asymmetric - - PowerPoint PPT Presentation

molecular design of bifunctional cp ru catalysts for
SMART_READER_LITE
LIVE PREVIEW

Molecular Design of Bifunctional Cp*Ru Catalysts for Asymmetric - - PowerPoint PPT Presentation

Molecular Design of Bifunctional Cp*Ru Catalysts for Asymmetric Synthesis Masato Ito & Takao Ikariya IMCE. Kyushu University & Tokyo Tech. Nov. 12, 2009 @ IKCOC-11 (OP-28) DIRECT HYDROGENATION OF POLARIZED CO BONDs H O O


slide-1
SLIDE 1

Molecular Design of Bifunctional Cp*Ru Catalysts for Asymmetric Synthesis Masato Ito & Takao Ikariya

  • IMCE. Kyushu University & Tokyo Tech.
  • Nov. 12, 2009 @ IKCOC-11 (OP-28)
slide-2
SLIDE 2

DIRECT HYDROGENATION OF POLARIZED C–O BONDs

R Y O catalyst + H2 R Y O H H

aldehyde ketone imide ester amide carbonate urea

R N R' O EWG R OR' O R N R' O EDG RO OR' O R2N NR'2 O R H O R R' O

now-resolved by Noyori’s catalysts (1995~) unresolved substrates with a less electrophilic carbonyl

slide-3
SLIDE 3

EXPLORATION WITH Cp*M–BASED COMPLEXES

R Y O catalyst + H2 R Y O H H

N

M X L N H R1 M X L N H R1 L = NMe2, , PPh2 M = FeII, RuII, CoIII, RhIII

2

He

5

B

8

O

9

F

10

Ne

11

Na

12

Mg

13

Al

14

Si

16

S

17

Cl

18

Ar

19

K

20

Ca

31

Ga

32

Ge

33

As

34

Se

35

Br

36

Kr

21

Sc

22

Ti

23

V

24

Cr

25

Mn

28

Ni

29

Cu

30

Zn

37

Rb

38

Sr

49

In

50

Sn

51

Sb

52

Te

53

I

54

Xe

39

Y

40

Zr

41

Nb

42

Mo

43

Tc

46

Pd

48

Cd

55

Cs

56

Ba

81

Tl

82

Pb

83

Bi

84

Po

85

At

86

Rn

57~71

72

Hf

73

Ta

74

W

75

Re

78

Pt

79

Au

80

Hg

87

Fr

88

Ra

113

Uut

114

Uuq

115

Uup

116

Uuh

118

Uuo

89~103

104

Rf

105

Db

106

Sg

107

Bh

108

Hs

109

Mt

110

Ds

111

Rg

112

Uub

1

H

4

Be

3

Li

47

Ag

7

N

15

P

6

C

26

Fe

27

Co

44

Ru

45

Rh

76

Os

77

Ir

molecular orchestration

at the ligand sphere of the central metal by judicious choice of coordinating elements

slide-4
SLIDE 4

PROTIC AMINE LIGANDS

N O O R2 R1 + HPPh2 TfOH NHR1 Ph2P R2 2 equiv –CO2 Organometallics, 2009, 28, 390 N O R1 (2 equiv) Li NHR1 OH HCl NHR1

n n n

–H2O M X Ph2 P N H R1 R2 M X L N H R1

n

slide-5
SLIDE 5

EXPLORATION WITH Cp*M–BASED COMPLEXES

R Y O catalyst + H2 R Y O H H

2

He

5

B

8

O

9

F

10

Ne

11

Na

12

Mg

13

Al

14

Si

16

S

17

Cl

18

Ar

19

K

20

Ca

31

Ga

32

Ge

33

As

34

Se

35

Br

36

Kr

21

Sc

22

Ti

23

V

24

Cr

25

Mn

28

Ni

29

Cu

30

Zn

37

Rb

38

Sr

49

In

50

Sn

51

Sb

52

Te

53

I

54

Xe

39

Y

40

Zr

41

Nb

42

Mo

43

Tc

46

Pd

48

Cd

55

Cs

56

Ba

81

Tl

82

Pb

83

Bi

84

Po

85

At

86

Rn

57~71

72

Hf

73

Ta

74

W

75

Re

78

Pt

79

Au

80

Hg

87

Fr

88

Ra

113

Uut

114

Uuq

115

Uup

116

Uuh

118

Uuo

89~103

104

Rf

105

Db

106

Sg

107

Bh

108

Hs

109

Mt

110

Ds

111

Rg

112

Uub

1

H

4

Be

3

Li

47

Ag

7

N

15

P

6

C

26

Fe

27

Co

44

Ru

45

Rh

76

Os

77

Ir

molecular orchestration

at the ligand sphere of the central metal by judicious choice of coordinating elements

N

Ru X L N H R1 Ru X L N H R1 L = NMe2, , PPh2

slide-6
SLIDE 6

Ru & CHELATING PROTIC AMINE LIGAND

R Y O catalyst + H2 R Y O H H

Basic media-assisted heterolysis of H2 Chemoselective delivery of activated H2

N

Ru X L N H R1 Ru X L N H R1 L = NMe2, , PPh2

slide-7
SLIDE 7

Me2 N Ru Cl Ph2 P N H2 aldehyde ketone lactone lactam carboxamide imide Cp*Ru(NN) Cp*Ru(PN) X X O X O X X O O O PH2 = 1 –30 atm, cat. = Ru + base (1:1) [substrate] = 0.02 –1.0 M in alcohol 30 –80 °C Ru Cl N N H2 Ru Cl N H2 N-acylcarbamate X O O O ester X X

REDUCIBLE POLARIZED C–O BONDS WITH H2

  • Chem. Commun. (Feature Article), 2007, 5134
  • J. Synth. Org. Chem., Jpn., 2008, 66, 1042.
  • Angew. Chem., Int. Ed., 2009, 48,

1324

slide-8
SLIDE 8
  • J. Am. Chem. Soc., 2007, 129, 290.

HYDROGENATION OF IMIDE WITH Cp*Ru(PN) CATALYSTS

+ H2 2-propanol 50 –80 ºC 1 –18 h Cp*RuCl(PN) KOt-Bu Ru:KOt-Bu = 1:1 (1 –5 mol%) [imide] = 0.02 –0.20 M 30 atm Ru Cl Ph2 P N H2 Cp*RuCl(PN) N O O R NHR O OH NHR O OH NHR O OH NHR O OH R

n

>99% yield

n

(n = 1 –4) (n = 1 –3) NH R O OH NHR O OH O RHNHO

slide-9
SLIDE 9

+ H2 2-propanol 80 ºC, 24 h Cp*RuCl(PN) KOt-Bu 30 atm Cp*RuCl(PN) Ru:KOt-Bu = 1:1 (10 mol%), [imide] = 0.20 M Ar = (3,4-OCH2O)C6H3 NAr O O NHAr O OH Rn Rn NHAr O OH 91–99% ee NHAr CH3 O OH 88% ee CONHAr 97% ee Ru Cl Ph2 P N H n n = 1,2 92% ee 91% ee * Rn CH2OH CONHAr 94% ee CH2OH CH2OH CONHAr CH2OH CONHAr CONHAr CH2OH CONHAr CH2OH 94% ee 97% ee

HYDROGENATIVE DESYMMETRIZATION OF IMIDES

to be published

slide-10
SLIDE 10

MOLECULAR STRUCTURES OF BICYCLIC IMIDES

slide-11
SLIDE 11

HYDROGENATIVE DESYMMETRIZATION OF IMIDES

to be published

+ H2 2-propanol 80 ºC, 24 h Cp*RuCl(PN) KOt-Bu 30 atm Cp*RuCl(PN) Ru:KOt-Bu = 1:1 (10 mol%), [imide] = 0.20 M Ar = (3,4-OCH2O)C6H3 NAr O O NHAr O OH Rn Rn NHAr O OH 91–99% ee NHAr CH3 O OH 88% ee CONHAr 97% ee Ru Cl Ph2 P N H n n = 1,2 92% ee 91% ee * Rn CH2OH CONHAr 94% ee CH2OH CH2OH CONHAr CH2OH CONHAr CONHAr CH2OH CONHAr CH2OH 94% ee 97% ee

slide-12
SLIDE 12

ASYMMETRIC SYNTHESIS OF PAROXETINE

NHAr 4-FC6H4 OH O 1) CBr4, PPh3 NH2Cl 4-FC6H4 Ar = 3,4-(OCH2O)C6H3

Paroxetine (SSRI)

2) NaH 3) CAN >99% ee 2-propanol H2 / Cp*RuCl(PN) NH 4-FC6H4 O O O O steps

R

F O O O O N

  • Pure. Appl. Chem., 2008, 80, 1047.
slide-13
SLIDE 13

HYDROGENATION OF PHTHALIDE

+ H2 2-propanol 100 ºC, 21 h Cp*RuCl(isoprene) Ligand NaOMe ester:Ru:Ligand:NaOMe = 100:1:1:25, [ester] = 1.0 M in 2-propanol 50 atm O O OH OH Ph2P NH2 >99% Ph2P NMe >99% Ph2P NMe2 <1% Me2N NH2 45% MeN NH2 83% MeN NMe 94% N NH2 >99% H2N NH2 81% H H H H

slide-14
SLIDE 14

120 100 80 60 10 30 50 20 40 60 80 100 conv, % ℃ atm

PRESSURE & TEMPERATURE EFFECT

+ H2 2-propanol 21 h Cp*RuCl(PyN) NaOMe ester:Ru:NaOMe = 100:1:25, [ester] = 1.0 M in 2-propanol O O OH OH Ru Cl N N H2 Cp*RuCl(PyN)

slide-15
SLIDE 15

SUBSTRATE SCOPE

+ H2 2-propanol (t-butanol*) 100 ºC, 21 –24h Cp*RuCl(PyN) NaOMe lactone:Ru:NaOMe = 100:1 –5:25, [lactone] = 1.0 –2.0 M 50 atm O O OH OH O O (0.1 mol%) R=Me* R=C2H5 Ph OR O CHF2 OC2H5 O R R=Ph R'=H R=Bn R'=H R=H R'=n-C5H11 (5 mol%) PhCF2 Ot-Bu O R' O O >99% Ru Cl N N H2 Cp*RuCl(PyN)

slide-16
SLIDE 16

SUBSTRATE SCOPE

+ H2 2-propanol (t-butanol*) 100 ºC, 21 –24h Cp*RuCl(PyN) NaOMe lactone:Ru:NaOMe = 100:1 –5:25, [lactone] = 1.0 –2.0 M 50 atm O O OH OH 660 TON (0.1 mol%) R=Me, >99%* R=C2H5, >99% Ph OH CHF2 OH R R=Ph R'=H, >99% R=Bn R'=H, >99% R=H R'=n-C5H11, 76% >99% (5 mol%) PhCF2 OH OH >99% Ru Cl N N H2 Cp*RuCl(PyN) OH OH R' OH

slide-17
SLIDE 17

ASYMMETRIC HYDROGENATION VIA DKR

+ H2 2-propanol 80 ºC, 48 h Cp*RuCl(chiral diamine) KOt-Bu lactone:Ru:KOt-Bu = 100:2:25, [lactone] = 1.0 M 50 atm O O Ph OH OH Ph 94 –97% yield MeN NMe 34% ee H2N NH2 20% ee H H Ph Ph Ph Ph MeN NMe 54% ee 67% ee (10 mol%, 60 ºC, 90 h) H H N NH2 29% ee H

slide-18
SLIDE 18

EFFECT OF SUB-STOICHIOMETRIC BASE

N lactone lactam carboxamide condition A with Cp*Ru(PN) A: PH2 = 30 atm, cat. = Ru + base (1:1), 80 °C B: PH2 = 50 atm, substrate + base (4:1), 100 °C Ru Cl N N H2 Ru Cl N N-acylcarbamate O O O ester H H Me Me O O O X X O O condition B with any Cp*Ru(LN) Ru Cl Ph2 P N H2

slide-19
SLIDE 19

HYDROGENATION OF N-Ph-γ-LACTAM

+ H2 t-butanol 100 ºC, 90 h Cp*RuCl(LN) NaOMe lactam:Ru:NaOMe = 100:10:30, [lactam] = 1.0 M 50 atm N O N OH H 82% yield Ru Cl Ph2 P N 66% yield H Me Ru Cl N N H2

slide-20
SLIDE 20

SUBSTRATE SCOPE

+ H2 t-butanol 100 ºC, 90 h Cp*RuCl(PyN) NaOMe lactam:Ru:NaOMe = 100:10:30, [lactam] = 1.0 M 50 atm N O HN OH R=C6H5, 99% R=CF2C6H5, 99% Rn Rn N O n=0, 83% n=1, 82% n=2, 91% n=3, 74%

n

N O R=F, 83% R=CF3, 90% R=OMe, 56% R N O H N O R R=4-CF3, 90% R=3,5-(CF3)2, 93% (48 h) Rn

slide-21
SLIDE 21

Co–workers

JSPS Kakenhi

Financial Support

  • Mr. Makoto Hirakawa
  • Dr. Akihide Osaku
  • Ms. Ayaka Sakaguchi
  • Ms. Miho Ashiarai
  • Dr. Akira Shiibashi
  • Mr. Yuji Shibata
  • Ms. Chika Kobayashi
  • Mr. Kentaro Yamaguchi
  • Ms. Lee-Wei Koo
  • Mr. Takashi Otsuka
  • Ms. Yasuko Oosawa
  • Mr. Naoki Sakamoto

Kawakami Memorial Foundation

  • Ms. Mariko Sugizawa
  • Dr. Sachiko Kitahara
  • Mr. Kensuke Yamamoto
  • Ms. Hiroko Komatsu
  • Dr. Yoshinori Endo
  • Mr. Masahiro Yamamura
  • Ms. Noriko Tejima
  • Mr. Akio Himizu
  • Mr. Akira Watanabe
  • Ms. Takako Noguchi
  • Mr. Ryo Watari

Taisho Pharmaceutical Co. Ltd

ACKNOWLEDGEMENT

The Asahi Glass Foundation